Literature DB >> 2175799

Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.

E A Kowaluk1, H L Fung.   

Abstract

S-nitrosothiols are potent vasodilators in vivo and in vitro, and have recently been proposed as possible endogenous precursors of endothelium-derived nitric oxide (NO). NO release from S-nitrosothiols has generally been assumed to be spontaneous, but this has not been proven. This hypothesis was examined by altering the NO release profiles of two S-nitrosothiols, those of S-nitroso-N-acetylpenicillamine (SNAP) and S-nitroso-glutathione (GSNO), and observing their relaxation potency on isolated endothelium-denuded rat aortic rings. Spontaneous degradation of SNAP and GSNO in tissue bathing medium (monitored by high-performance liquid chromatography) and the associated NO release (assessed by chemiluminescence detection of headspace NO) were enhanced in the presence of 100 microM N-acetylpenicillamine and inhibited in the presence of 100 U/ml superoxide dismutase. However, the relaxant effects of SNAP and GSNO were enhanced in the presence of superoxide dismutase, and diminished in the presence of N-acetylpenicillamine. In addition, the relaxation potencies of SNAP, GSNO, S-nitrosocystein, S-nitroso-N-acetylcysteine and S-nitroso-coenzyme A were not correlated with spontaneous NO generation. These findings therefore argue against spontaneous liberation of NO as a predominant mechanism of S-nitrosothiol action. The highly polar SNAP, GSNO, S-nitrosocysteine and S-nitroso-N-acetylcysteine (octanol, pH 7.4 buffer partition coefficient from less than .025-.052) and the bulky and polar S-nitroso-coenzyme A (MW 797) have similar relaxation potencies, indicating that intracellular penetration of intact S-nitrosothiols may not be required for activity. NO generation from SNAP was examined in subcellular fractions of bovine coronary arterial smooth muscle cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175799

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  51 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

3.  Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system.

Authors:  K E Wiley; A P Davenport
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Interactions of copper with glycated proteins: possible involvement in the etiology of diabetic neuropathy.

Authors:  John W Eaton; Mingwei Qian
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

5.  Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart.

Authors:  Hideyuki Ishida; Naoko Higashijima; Yuki Hirota; Chokoh Genka; Hiroe Nakazawa; Haruaki Nakaya; Toshiaki Sato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-18       Impact factor: 3.000

6.  Influence of S-nitrosothiols and nitrate tolerance in the rat gastric fundus.

Authors:  A J Barbier; R A Lefebvre
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Non-adrenergic, non-cholinergic relaxation of the bovine retractor penis muscle: role of S-nitrosothiols.

Authors:  X Liu; J S Gillespie; W Martin
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Regional and cardiac haemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats.

Authors:  S M Gardiner; P A Kemp; T Bennett; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Activity of nitric oxide-generating compounds against encephalomyocarditis virus.

Authors:  E Guillemard; M Geniteau-Legendre; R Kergot; G Lemaire; J F Petit; C Labarre; A M Quero
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.